ArticleEuropean journal of nuclear medicine and molecular imaging2008

Development and evaluation of peptidic ligands targeting tumour-associated urokinase plasminogen activator receptor (uPAR) for use in alpha-emitter therapy for disseminated ovarian cancer.

Sebastian Knör et al.PubMed ↗Publisher ↗

No numbers read from the abstract.